IVERMECTIN
| Brand name | SOOLANTRA |
|---|---|
| Active ingredient | IVERMECTIN |
| Strength | 1% |
| Dosage form | CREAM |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | December 2014 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9233118 | March 2034 | use U-1631 |
| 9089587 | March 2034 | use U-1631 |
| 9233117 | March 2034 | use U-1631 |
| 9782425 | March 2034 | use U-1631 |
| 10206939 | March 2034 | use U-1631 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.